Rodman & Renshaw initiated coverage of Rein Therapeutics (RNTX) with a Buy rating and $8 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Disclaimer & DisclosureReport an Issue
